FY2024 PBT of RM 109.9M and gearing of 0.2x mark the cleanest balance sheet in five years, but EMS USD receivables and packaging input-cost volatility remain the two live exposures.
Revenue softened from RM 1.23B in FY2023 to RM 1.09B in FY2024 (−11.0%), but EBITDA margin expanded from 10.5% to 16.3% as CBB completed phase one of its strategic reset and Kaiserkorp was divested for a RM 56.3M gain. PBT rose to RM 109.9M, PATAMI to RM 73.1M (EPS 13.61 sen), and ROCE jumped to 10.2%.
Total borrowings dropped to RM 175M post-Sukuk repayment, taking gearing from 0.6x in FY2020 to 0.2x. Cash of RM 385.6M and dividend of 6.5 sen/share signal headroom for capital deployment. The live exposure is USD/MYR on CPI EMS receivables and resin / paper pulp input costs for Toyoplas and CBB.